The following adverse reactions have been reported and, within each category, are listed in order of decreasing severity.
Body As A Whole: Weakness.
Cardiovascular:Hypotension including ortho-static hypotension (may be aggravated by alcohol, barbiturates, narcotics or antihypertensive drugs).
Digestive:Pancreatitis, jaundice (intrahepatic cholestatic jaundice), diarrhea, vomiting, sialadenitis, cramping, constipation, gastric irritation, nausea, anorexia.
Hematologic:Aplastic anemia, agranulocytosis, leukopenia, hemolytic anemia, thrombocytopenia.
Hypersensitivity:Anaphylactic reactions, necrotizing angiitis (vasculitis and cutaneous vasculitis), respiratory distress including pneumonitis and pulmonary edema, photosensitivity, fever, urticaria, rash, purpura.
Metabolic:Electrolyte imbalance (see
PRECAUTIONS), hyperglycemia, glycosuria, hyperuricemia.
Musculoskeletal:Muscle spasm.
Nervous System/Psychiatric:Vertigo, paresthesias, dizziness, headache, restlessness.
Renal:Renal failure, renal dysfunction, interstitial nephritis. (See
WARNINGS.
)
Skin:Erythema multiforme including Stevens-Johnson syndrome, exfoliative dermatitis including toxic epidermal necrolysis, alopecia.
Special Senses:Transient blurred vision, xanthopsia.
Urogenital:Impotence.
Whenever adverse reactions are moderate or severe, thiazide dosage should be reduced or therapy withdrawn.
To report SUSPECTED ADVERSE REACTIONS, contact Advagen Pharma Ltd. at +1-866-488-0312 or FDA at 1-800-FDA-1088 or
www.fda.gov/medwatch.